Quantcast

Lipid vesicular nanocarrier: Quick encapsulation efficiency determination and transcutaneous application

Research paper by Yibang Zhang, Weibeng Ng, Xue Feng, Fangying Cao, Huaxi Xu

Indexed on: 09 Nov '16Published on: 08 Nov '16Published in: International Journal of Pharmaceutics



Abstract

Nanoscale delivery systems have been widely investigated to overcome the penetration barrier of stratum corneum for effective transcutaneous application. The aim of this study is the development of effective vesicular formulations of ovalbumin and saponin which are able to promote penetration through the skin layers. Three kinds of vesicular formulations have been investigated as carriers, including liposomes, transfersomes and ethosomes, in which cholesterol and/or cationic lipid stearylamine are incorporated. The impact of membrane composition variations on the protein entrapment has been evaluated for each vesicle type. Formulations were characterized for particle size, polydispersity and encapsulation efficiency. The best formulations for each type of vesicle were subjected to in vivo transdermal immunization in mice. Among the three kinds of vesicular carrier, ethosomal nano carrier not only showed the best stability over a two months’ storage, but also enabled the highest increase in the titer of serum antibody. In this regard, cationic nano-ethosomes can be considered as a promising vesicular carrier for transdermal vaccines. Meanwhile, we have developed a simple method to determine encapsulation efficiency of vesicular systems, which has potential application as a high throughput screening for vesicular formulations.

Graphical abstract 10.1016/j.ijpharm.2016.11.011.jpg
Figure 10.1016/j.ijpharm.2016.11.011.0.jpg
Figure 10.1016/j.ijpharm.2016.11.011.1.jpg
Figure 10.1016/j.ijpharm.2016.11.011.2.jpg
Figure 10.1016/j.ijpharm.2016.11.011.3.jpg
Figure 10.1016/j.ijpharm.2016.11.011.4.jpg